✦ LIBER ✦

Plasma neuropeptide Y is reduced in patients with Alzheimer's disease

✍ Scribed by Seiji Koide; Hiroshi Onishi; Hiroshi Hashimoto; Toshihiro Kai; Sakae Yamagami

Book ID: 116125046
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 272 KB
Volume: 198
Category: Article
ISSN: 0304-3940
DOI: 10.1016/0304-3940(95)11973-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

686 Plasma somatostatin and neuropeptide

686 Plasma somatostatin and neuropeptide Y are reduced in patients with Alzheimer's disease

✍ S. Koide; H. Onishi; H. Hashimoto; T. Kai; Y. Nakamura; M. Tani; S. Yamagami 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Neuropeptide Y immunoreactivity is reduc

Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease

✍ Dr M. Flint Beal; Michael F. Mazurek; Geetinder K. Chattha; Clive N. Svendsen; E 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 670 KB

Plasma urate in patients with Alzheimer'

Plasma urate in patients with Alzheimer's disease

✍ Said Ramdane 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Phosphatidylinositol Kinase Is Reduced i

Phosphatidylinositol Kinase Is Reduced in Alzheimer's Disease

✍ J. Jolles; J. Bothmer; M. Markerink; R. Ravid 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 439 KB

Somatostatin and neuropeptide Y immunore

Somatostatin and neuropeptide Y immunoreactivity in parkinson's disease dementia with alzheimer's changes

✍ M. Flint Beal; Ross A. Clevens; Michael F. Mazurek 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 530 KB

Decreased plasma antioxidants in patient

Decreased plasma antioxidants in patients with Alzheimer's disease

✍ Tae-Suk Kim; Chi-Un Pae; Su-Jung Yoon; Woo-Young Jang; Nam Jin Lee; Jung-Jin Kim 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 1 views

## Objectives: It has been suggested that oxidative injuries have an important role in the pathogenesis of alzheimer's disease (ad). in this study, we assess whether the plasma levels of albumin, bilirubin, and uric acid would be altered in the ad patients compared to those of the healthy controls.